
Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting
Las Vegas, Nevada 08 February 2026 - 13 February 2026
IV iron tied to higher risk of adverse perinatal outcomes in women with maternal IDA
02 Mar 2026
bởiAudrey Abella
In a study presented at SMFM 2026, IV iron therapy is associated with a higher risk of certain adverse maternal and neonatal complications in women with iron deficiency anaemia (IDA) in pregnancy and postpartum.
IV iron tied to higher risk of adverse perinatal outcomes in women with maternal IDA
02 Mar 2026
Aspirin use at first prenatal visit prevents pre-eclampsia
26 Feb 2026
bởiStephen Padilla
Prescribing daily aspirin at the first prenatal visit may result in the prevention of severe pre-eclampsia in women with or without chronic hypertension, reports a study presented at SMFM 2026.
Aspirin use at first prenatal visit prevents pre-eclampsia
26 Feb 2026
IV FCM superior to oral iron for postpartum anaemia
25 Feb 2026
bởiStephen Padilla
Single-dose intravenous ferric carboxymaltose (IV FCM) is more effective than oral iron in treating postpartum anaemia and improving haemoglobin (Hb) at 6 weeks, a study has shown.




